Research and development Driving scientific innovation to deliver the next generation of transformational medicines and vaccines for patients
Read morePress releases
- ViiV Healthcare files submissions to the FDA and EMA for the first-ever dispersible formulation of dolutegravir (DTG) for children living with HIV
- ViiV Healthcare submits New Drug Application to the FDA for fostemsavir, an investigational, first-in-class attachment inhibitor for the treatment of HIV in adults with few treatment options available
- ViiV Healthcare announces exclusive licensing agreement with the National Institutes of Health for investigational “bNAb” with potential for long-acting HIV treatment and prevention
Tweets from GSK
-
GSK @GSK
No single organisation can achieve #UHC on its own. This #UHCDay learn how we are working with @comicrelief in new, innovative ways to tackle #malaria and strengthen #HealthSystems so that we can help drive progress towards UHC. gsk.to/2ryBrCi
about 10 hours ago
-
GSK @GSK
#DYK multiple #myeloma can relapse or stop responding to medication? That’s why we’re dedicated to researching newer, more effective treatments to stop blood #cancer in its tracks. #ASH19
about 3 days ago -
GSK @GSK
Our scientists are working hard to find candidate vaccines more quickly and revolutionise the way vaccines are manufactured. Find out how… twitter.com/BBCBusiness/st…
about 4 days ago
